يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Torija Recasens, Alba"', وقت الاستعلام: 1.45s تنقيح النتائج
  1. 1
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Ministerio de Economía y Competitividad ICI14/00242; Ministerio de Economía y Competitividad PI16/01321; Instituto de Salud Carlos III PI19/01710; Frontiers in immunology; Vol. 13 (july 2022); https://ddd.uab.cat/record/284264Test; urn:10.3389/fimmu.2022.918887; urn:oai:ddd.uab.cat:284264; urn:pmcid:PMC9374104; urn:pmc-uid:9374104; urn:pmid:35967428; urn:oai:pubmedcentral.nih.gov:9374104

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Crespo E, Torija A, Donadeu L Laboratori de Nefrologia i Trasplantament Renal, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vidal-Alabró A, Fontova P, Mocka S Experimental Nephrology and Transplantation Laboratory, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain. Jouve T Laboratori de Nefrologia i Trasplantament Renal, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Faculty of Health, Université Grenoble Alpes, Grenoble, France. Institute for Advanced Biosciences, INSERM 1209, CNRS 5309, Grenoble, France. Stein M Berlin Center for Advanced Therapies (BeCAT), Berlin, Germany. Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany. Berlin Institute of Health (BIH), Berlin, Germany. Meneghini M, Bestard O Laboratori de Nefrologia i Trasplantament Renal, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Unitat de Trasplantament Renal, Servei de Nefrologia, Vall d’Hebron Hospital, Barcelona, Spain. Moreso F Unitat de Trasplantament Renal, Servei de Nefrologia, Vall d’Hebron Hospital, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Immunology;13; https://doi.org/10.3389/fimmu.2022.869554Test; Crespo E, Vidal-Alabró A, Jouve T, Fontova P, Stein M, Mocka S, et al. Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation. Front Immunol. 2022 Jun;13:869554.; https://hdl.handle.net/11351/8204Test; 000823422300001

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Pernin V Kidney Transplant Unit, Nephrology Department. Montpellier University Hospital, Montpellier, France. Meneghini M, Bestard O Unitat de Trasplantament Renal, Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Laboratori de Nefrologia i Trasplantament Renal, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Torija A, Donadeu L, Polo C Laboratori de Nefrologia i Trasplantament Renal, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Jouve T Laboratori de Nefrologia i Trasplantament Renal, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Kidney transplant Unit, Nephrology Department. Grenoble University Hospital, Grenoble, France. Del Bello A Centro Nacional de Gripe de Valladolid, Universidad de Valladolid, Valladolid, Spain. Sanz-Muñoz I Centro Nacional de Gripe, Valladolid Universidad de Valladolid, Valladolid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Immunology;13; https://doi.org/10.3389/fimmu.2022.918887Test; info:eu-repo/grantAgreement/EC/H2020/754995; Pernin V, Meneghini M, Torija A, Jouve T, Del Bello A, Sanz-Muñoz I, et al. Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept. Front Immunol. 2022 Jul 29;13:918887.; https://hdl.handle.net/11351/8385Test; 000840654600001

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Meneghini M, Bestard O Unitat de Trasplantament Hepàtic, Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Perona A Department of Medicine, Barcelona University, Barcelona, Spain. Crespo E, Torija A, Donadeu L Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Bemelman F Renal Transplant Unit, Department of Internal Medicine, Amsterdam University Medical Centers, Academic Medical Center - University of Amsterdam, Amsterdam, Netherlands. Reinke P Berlin Center for Advanced Therapies (BeCAT), Berlin Institute of Health Center for Regenerative Therapies (BCRT) and Department of Nephrology and Intensive Care, Charité Universitätsmedizin Berlin, Berlin Institute of Health, Berlin, Germany. Viklicky O Transplant Laboratory, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia. Department of Nephrology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia. Zuñiga J Unitat de Trasplantament Hepàtic, Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Immunology;13; https://doi.org/10.3389/fimmu.2022.924825Test; info:eu-repo/grantAgreement/EC/FP7/305147; Meneghini M, Perona A, Crespo E, Bemelman F, Reinke P, Viklicky O, et al. On the clinical relevance of using complete high-resolution HLA typing for an accurate interpretation of posttransplant immune-mediated graft outcomes. Front Immunol. 2022 Sep 29;13:924825.; https://hdl.handle.net/11351/8515Test; 000868546400001